GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (FRA:4TO) » Definitions » Total Equity

Mainz Biomed NV (FRA:4TO) Total Equity : €-3.85 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Total Equity?

Mainz Biomed NV's total equity for the quarter that ended in Jun. 2024 was €-3.85 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Mainz Biomed NV Total Equity Historical Data

The historical data trend for Mainz Biomed NV's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Total Equity Chart

Mainz Biomed NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
-1.76 -2.25 5.63 13.31 2.98

Mainz Biomed NV Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.04 4.78 3.23 2.98 -3.85

Mainz Biomed NV Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Mainz Biomed NV's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=14.13-11.151
=2.98

Mainz Biomed NV's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=7.854-11.699
=-3.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mainz Biomed NV Total Equity Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (FRA:4TO) » Definitions » Total Equity
Comparable Companies
BIAF PMDI PRPO PRPH APDN STRR XWEL IDXG TTOO CHEK TMO DHR XSWX:LONN A IDXX IQV SHSE:603259 MTD WAT NTRA
Traded in Other Exchanges
MYNZ:USA
Address
Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129
Website
https://www.mainzbiomed.com
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Mainz Biomed NV Headlines

No Headlines